Tリンパ球活性化抗原CD86の世界市場（～2026年）

• 英文タイトル：Global T Lymphocyte Activation Antigen CD86 Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY10451 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はTリンパ球活性化抗原CD86のグローバル市場について調査・分析したレポートです。種類別（アバタセプト、アバタセプトバイオシミラー、KAHR-102）市場規模、用途別（筋骨格系障害、移植片対宿主病、ループス腎炎、ネフローゼ症候群、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別Tリンパ球活性化抗原CD86の競争状況、市場シェア ・世界のTリンパ球活性化抗原CD86市場：種類別市場規模 2015年-2020年（アバタセプト、アバタセプトバイオシミラー、KAHR-102） ・世界のTリンパ球活性化抗原CD86市場：種類別市場規模予測 2021年-2026年（アバタセプト、アバタセプトバイオシミラー、KAHR-102） ・世界のTリンパ球活性化抗原CD86市場：用途別市場規模 2015年-2020年（筋骨格系障害、移植片対宿主病、ループス腎炎、ネフローゼ症候群、その他） ・世界のTリンパ球活性化抗原CD86市場：用途別市場規模予測 2021年-2026年（筋骨格系障害、移植片対宿主病、ループス腎炎、ネフローゼ症候群、その他） ・北米のTリンパ球活性化抗原CD86市場分析：米国、カナダ ・ヨーロッパのTリンパ球活性化抗原CD86市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのTリンパ球活性化抗原CD86市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のTリンパ球活性化抗原CD86市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのTリンパ球活性化抗原CD86市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：3SBio Inc、Bristol-Myers Squibb Co、KAHR medical Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global T Lymphocyte Activation Antigen CD86 Market
The global T Lymphocyte Activation Antigen CD86 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global T Lymphocyte Activation Antigen CD86 Scope and Market Size
T Lymphocyte Activation Antigen CD86 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global T Lymphocyte Activation Antigen CD86 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the T Lymphocyte Activation Antigen CD86 market is segmented into
Abatacept
Abatacept Biosimilar
KAHR-102

Segment by Application, the T Lymphocyte Activation Antigen CD86 market is segmented into
Musculoskeletal Disorders
Graft Versus Host Disease
Lupus Nephritis
Nephrotic Syndrome
Others

Regional and Country-level Analysis
The T Lymphocyte Activation Antigen CD86 market is analysed and market size information is provided by regions (countries).
The key regions covered in the T Lymphocyte Activation Antigen CD86 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and T Lymphocyte Activation Antigen CD86 Market Share Analysis
T Lymphocyte Activation Antigen CD86 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in T Lymphocyte Activation Antigen CD86 business, the date to enter into the T Lymphocyte Activation Antigen CD86 market, T Lymphocyte Activation Antigen CD86 product introduction, recent developments, etc.

The major vendors covered:
3SBio Inc
Bristol-Myers Squibb Co
KAHR medical Ltd
…

レポート目次

---

1 Study Coverage
1.1 T Lymphocyte Activation Antigen CD86 Product Introduction
1.2 Market Segments
1.3 Key T Lymphocyte Activation Antigen CD86 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global T Lymphocyte Activation Antigen CD86 Market Size Growth Rate by Type
1.4.2 Abatacept
1.4.3 Abatacept Biosimilar
1.4.4 KAHR-102
1.5 Market by Application
1.5.1 Global T Lymphocyte Activation Antigen CD86 Market Size Growth Rate by Application
1.5.2 Musculoskeletal Disorders
1.5.3 Graft Versus Host Disease
1.5.4 Lupus Nephritis
1.5.5 Nephrotic Syndrome
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global T Lymphocyte Activation Antigen CD86 Market Size, Estimates and Forecasts
2.1.1 Global T Lymphocyte Activation Antigen CD86 Revenue 2015-2026
2.1.2 Global T Lymphocyte Activation Antigen CD86 Sales 2015-2026
2.2 Global T Lymphocyte Activation Antigen CD86, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global T Lymphocyte Activation Antigen CD86 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global T Lymphocyte Activation Antigen CD86 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global T Lymphocyte Activation Antigen CD86 Competitor Landscape by Players
3.1 T Lymphocyte Activation Antigen CD86 Sales by Manufacturers
3.1.1 T Lymphocyte Activation Antigen CD86 Sales by Manufacturers (2015-2020)
3.1.2 T Lymphocyte Activation Antigen CD86 Sales Market Share by Manufacturers (2015-2020)
3.2 T Lymphocyte Activation Antigen CD86 Revenue by Manufacturers
3.2.1 T Lymphocyte Activation Antigen CD86 Revenue by Manufacturers (2015-2020)
3.2.2 T Lymphocyte Activation Antigen CD86 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global T Lymphocyte Activation Antigen CD86 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by T Lymphocyte Activation Antigen CD86 Revenue in 2019
3.2.5 Global T Lymphocyte Activation Antigen CD86 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 T Lymphocyte Activation Antigen CD86 Price by Manufacturers
3.4 T Lymphocyte Activation Antigen CD86 Manufacturing Base Distribution, Product Types
3.4.1 T Lymphocyte Activation Antigen CD86 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers T Lymphocyte Activation Antigen CD86 Product Type
3.4.3 Date of International Manufacturers Enter into T Lymphocyte Activation Antigen CD86 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global T Lymphocyte Activation Antigen CD86 Market Size by Type (2015-2020)
4.1.1 Global T Lymphocyte Activation Antigen CD86 Sales by Type (2015-2020)
4.1.2 Global T Lymphocyte Activation Antigen CD86 Revenue by Type (2015-2020)
4.1.3 T Lymphocyte Activation Antigen CD86 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global T Lymphocyte Activation Antigen CD86 Market Size Forecast by Type (2021-2026)
4.2.1 Global T Lymphocyte Activation Antigen CD86 Sales Forecast by Type (2021-2026)
4.2.2 Global T Lymphocyte Activation Antigen CD86 Revenue Forecast by Type (2021-2026)
4.2.3 T Lymphocyte Activation Antigen CD86 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global T Lymphocyte Activation Antigen CD86 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global T Lymphocyte Activation Antigen CD86 Market Size by Application (2015-2020)
5.1.1 Global T Lymphocyte Activation Antigen CD86 Sales by Application (2015-2020)
5.1.2 Global T Lymphocyte Activation Antigen CD86 Revenue by Application (2015-2020)
5.1.3 T Lymphocyte Activation Antigen CD86 Price by Application (2015-2020)
5.2 T Lymphocyte Activation Antigen CD86 Market Size Forecast by Application (2021-2026)
5.2.1 Global T Lymphocyte Activation Antigen CD86 Sales Forecast by Application (2021-2026)
5.2.2 Global T Lymphocyte Activation Antigen CD86 Revenue Forecast by Application (2021-2026)
5.2.3 Global T Lymphocyte Activation Antigen CD86 Price Forecast by Application (2021-2026)

6 North America
6.1 North America T Lymphocyte Activation Antigen CD86 by Country
6.1.1 North America T Lymphocyte Activation Antigen CD86 Sales by Country
6.1.2 North America T Lymphocyte Activation Antigen CD86 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America T Lymphocyte Activation Antigen CD86 Market Facts & Figures by Type
6.3 North America T Lymphocyte Activation Antigen CD86 Market Facts & Figures by Application

7 Europe
7.1 Europe T Lymphocyte Activation Antigen CD86 by Country
7.1.1 Europe T Lymphocyte Activation Antigen CD86 Sales by Country
7.1.2 Europe T Lymphocyte Activation Antigen CD86 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe T Lymphocyte Activation Antigen CD86 Market Facts & Figures by Type
7.3 Europe T Lymphocyte Activation Antigen CD86 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific T Lymphocyte Activation Antigen CD86 by Region
8.1.1 Asia Pacific T Lymphocyte Activation Antigen CD86 Sales by Region
8.1.2 Asia Pacific T Lymphocyte Activation Antigen CD86 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific T Lymphocyte Activation Antigen CD86 Market Facts & Figures by Type
8.3 Asia Pacific T Lymphocyte Activation Antigen CD86 Market Facts & Figures by Application

9 Latin America
9.1 Latin America T Lymphocyte Activation Antigen CD86 by Country
9.1.1 Latin America T Lymphocyte Activation Antigen CD86 Sales by Country
9.1.2 Latin America T Lymphocyte Activation Antigen CD86 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America T Lymphocyte Activation Antigen CD86 Market Facts & Figures by Type
9.3 Central & South America T Lymphocyte Activation Antigen CD86 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa T Lymphocyte Activation Antigen CD86 by Country
10.1.1 Middle East and Africa T Lymphocyte Activation Antigen CD86 Sales by Country
10.1.2 Middle East and Africa T Lymphocyte Activation Antigen CD86 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa T Lymphocyte Activation Antigen CD86 Market Facts & Figures by Type
10.3 Middle East and Africa T Lymphocyte Activation Antigen CD86 Market Facts & Figures by Application

11 Company Profiles
11.1 3SBio Inc
11.1.1 3SBio Inc Corporation Information
11.1.2 3SBio Inc Description and Business Overview
11.1.3 3SBio Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3SBio Inc T Lymphocyte Activation Antigen CD86 Products Offered
11.1.5 3SBio Inc Related Developments
11.2 Bristol-Myers Squibb Co
11.2.1 Bristol-Myers Squibb Co Corporation Information
11.2.2 Bristol-Myers Squibb Co Description and Business Overview
11.2.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Co T Lymphocyte Activation Antigen CD86 Products Offered
11.2.5 Bristol-Myers Squibb Co Related Developments
11.3 KAHR medical Ltd
11.3.1 KAHR medical Ltd Corporation Information
11.3.2 KAHR medical Ltd Description and Business Overview
11.3.3 KAHR medical Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 KAHR medical Ltd T Lymphocyte Activation Antigen CD86 Products Offered
11.3.5 KAHR medical Ltd Related Developments
11.1 3SBio Inc
11.1.1 3SBio Inc Corporation Information
11.1.2 3SBio Inc Description and Business Overview
11.1.3 3SBio Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3SBio Inc T Lymphocyte Activation Antigen CD86 Products Offered
11.1.5 3SBio Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 T Lymphocyte Activation Antigen CD86 Market Estimates and Projections by Region
12.1.1 Global T Lymphocyte Activation Antigen CD86 Sales Forecast by Regions 2021-2026
12.1.2 Global T Lymphocyte Activation Antigen CD86 Revenue Forecast by Regions 2021-2026
12.2 North America T Lymphocyte Activation Antigen CD86 Market Size Forecast (2021-2026)
12.2.1 North America: T Lymphocyte Activation Antigen CD86 Sales Forecast (2021-2026)
12.2.2 North America: T Lymphocyte Activation Antigen CD86 Revenue Forecast (2021-2026)
12.2.3 North America: T Lymphocyte Activation Antigen CD86 Market Size Forecast by Country (2021-2026)
12.3 Europe T Lymphocyte Activation Antigen CD86 Market Size Forecast (2021-2026)
12.3.1 Europe: T Lymphocyte Activation Antigen CD86 Sales Forecast (2021-2026)
12.3.2 Europe: T Lymphocyte Activation Antigen CD86 Revenue Forecast (2021-2026)
12.3.3 Europe: T Lymphocyte Activation Antigen CD86 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific T Lymphocyte Activation Antigen CD86 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: T Lymphocyte Activation Antigen CD86 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: T Lymphocyte Activation Antigen CD86 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: T Lymphocyte Activation Antigen CD86 Market Size Forecast by Region (2021-2026)
12.5 Latin America T Lymphocyte Activation Antigen CD86 Market Size Forecast (2021-2026)
12.5.1 Latin America: T Lymphocyte Activation Antigen CD86 Sales Forecast (2021-2026)
12.5.2 Latin America: T Lymphocyte Activation Antigen CD86 Revenue Forecast (2021-2026)
12.5.3 Latin America: T Lymphocyte Activation Antigen CD86 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa T Lymphocyte Activation Antigen CD86 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: T Lymphocyte Activation Antigen CD86 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: T Lymphocyte Activation Antigen CD86 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: T Lymphocyte Activation Antigen CD86 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key T Lymphocyte Activation Antigen CD86 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 T Lymphocyte Activation Antigen CD86 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. T Lymphocyte Activation Antigen CD86 Market Segments
Table 2. Ranking of Global Top T Lymphocyte Activation Antigen CD86 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global T Lymphocyte Activation Antigen CD86 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Abatacept
Table 5. Major Manufacturers of Abatacept Biosimilar
Table 6. Major Manufacturers of KAHR-102
Table 7. Global T Lymphocyte Activation Antigen CD86 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global T Lymphocyte Activation Antigen CD86 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global T Lymphocyte Activation Antigen CD86 Sales by Regions 2015-2020 (K Pcs)
Table 10. Global T Lymphocyte Activation Antigen CD86 Sales Market Share by Regions (2015-2020)
Table 11. Global T Lymphocyte Activation Antigen CD86 Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global T Lymphocyte Activation Antigen CD86 Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global T Lymphocyte Activation Antigen CD86 Sales Share by Manufacturers (2015-2020)
Table 14. Global T Lymphocyte Activation Antigen CD86 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global T Lymphocyte Activation Antigen CD86 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Lymphocyte Activation Antigen CD86 as of 2019)
Table 16. T Lymphocyte Activation Antigen CD86 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. T Lymphocyte Activation Antigen CD86 Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers T Lymphocyte Activation Antigen CD86 Price (2015-2020) (USD/Pcs)
Table 19. T Lymphocyte Activation Antigen CD86 Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers T Lymphocyte Activation Antigen CD86 Product Type
Table 21. Date of International Manufacturers Enter into T Lymphocyte Activation Antigen CD86 Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global T Lymphocyte Activation Antigen CD86 Sales by Type (2015-2020) (K Pcs)
Table 24. Global T Lymphocyte Activation Antigen CD86 Sales Share by Type (2015-2020)
Table 25. Global T Lymphocyte Activation Antigen CD86 Revenue by Type (2015-2020) (US$ Million)
Table 26. Global T Lymphocyte Activation Antigen CD86 Revenue Share by Type (2015-2020)
Table 27. T Lymphocyte Activation Antigen CD86 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global T Lymphocyte Activation Antigen CD86 Sales by Application (2015-2020) (K Pcs)
Table 29. Global T Lymphocyte Activation Antigen CD86 Sales Share by Application (2015-2020)
Table 30. North America T Lymphocyte Activation Antigen CD86 Sales by Country (2015-2020) (K Pcs)
Table 31. North America T Lymphocyte Activation Antigen CD86 Sales Market Share by Country (2015-2020)
Table 32. North America T Lymphocyte Activation Antigen CD86 Revenue by Country (2015-2020) (US$ Million)
Table 33. North America T Lymphocyte Activation Antigen CD86 Revenue Market Share by Country (2015-2020)
Table 34. North America T Lymphocyte Activation Antigen CD86 Sales by Type (2015-2020) (K Pcs)
Table 35. North America T Lymphocyte Activation Antigen CD86 Sales Market Share by Type (2015-2020)
Table 36. North America T Lymphocyte Activation Antigen CD86 Sales by Application (2015-2020) (K Pcs)
Table 37. North America T Lymphocyte Activation Antigen CD86 Sales Market Share by Application (2015-2020)
Table 38. Europe T Lymphocyte Activation Antigen CD86 Sales by Country (2015-2020) (K Pcs)
Table 39. Europe T Lymphocyte Activation Antigen CD86 Sales Market Share by Country (2015-2020)
Table 40. Europe T Lymphocyte Activation Antigen CD86 Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe T Lymphocyte Activation Antigen CD86 Revenue Market Share by Country (2015-2020)
Table 42. Europe T Lymphocyte Activation Antigen CD86 Sales by Type (2015-2020) (K Pcs)
Table 43. Europe T Lymphocyte Activation Antigen CD86 Sales Market Share by Type (2015-2020)
Table 44. Europe T Lymphocyte Activation Antigen CD86 Sales by Application (2015-2020) (K Pcs)
Table 45. Europe T Lymphocyte Activation Antigen CD86 Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific T Lymphocyte Activation Antigen CD86 Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific T Lymphocyte Activation Antigen CD86 Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific T Lymphocyte Activation Antigen CD86 Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific T Lymphocyte Activation Antigen CD86 Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific T Lymphocyte Activation Antigen CD86 Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific T Lymphocyte Activation Antigen CD86 Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific T Lymphocyte Activation Antigen CD86 Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific T Lymphocyte Activation Antigen CD86 Sales Market Share by Application (2015-2020)
Table 54. Latin America T Lymphocyte Activation Antigen CD86 Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America T Lymphocyte Activation Antigen CD86 Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa T Lymphocyte Activation Antigen CD86 Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America T Lymphocyte Activation Antigen CD86 Revenue Market Share by Country (2015-2020)
Table 58. Latin America T Lymphocyte Activation Antigen CD86 Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America T Lymphocyte Activation Antigen CD86 Sales Market Share by Type (2015-2020)
Table 60. Latin America T Lymphocyte Activation Antigen CD86 Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America T Lymphocyte Activation Antigen CD86 Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa T Lymphocyte Activation Antigen CD86 Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa T Lymphocyte Activation Antigen CD86 Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa T Lymphocyte Activation Antigen CD86 Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa T Lymphocyte Activation Antigen CD86 Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa T Lymphocyte Activation Antigen CD86 Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa T Lymphocyte Activation Antigen CD86 Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa T Lymphocyte Activation Antigen CD86 Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa T Lymphocyte Activation Antigen CD86 Sales Market Share by Application (2015-2020)
Table 70. 3SBio Inc Corporation Information
Table 71. 3SBio Inc Description and Major Businesses
Table 72. 3SBio Inc T Lymphocyte Activation Antigen CD86 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. 3SBio Inc Product
Table 74. 3SBio Inc Recent Development
Table 75. Bristol-Myers Squibb Co Corporation Information
Table 76. Bristol-Myers Squibb Co Description and Major Businesses
Table 77. Bristol-Myers Squibb Co T Lymphocyte Activation Antigen CD86 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb Co Product
Table 79. Bristol-Myers Squibb Co Recent Development
Table 80. KAHR medical Ltd Corporation Information
Table 81. KAHR medical Ltd Description and Major Businesses
Table 82. KAHR medical Ltd T Lymphocyte Activation Antigen CD86 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. KAHR medical Ltd Product
Table 84. KAHR medical Ltd Recent Development
Table 85. Global T Lymphocyte Activation Antigen CD86 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 86. Global T Lymphocyte Activation Antigen CD86 Sales Market Share Forecast by Regions (2021-2026)
Table 87. Global T Lymphocyte Activation Antigen CD86 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 88. Global T Lymphocyte Activation Antigen CD86 Revenue Market Share Forecast by Regions (2021-2026)
Table 89. North America: T Lymphocyte Activation Antigen CD86 Sales Forecast by Country (2021-2026) (K Pcs)
Table 90. North America: T Lymphocyte Activation Antigen CD86 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 91. Europe: T Lymphocyte Activation Antigen CD86 Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. Europe: T Lymphocyte Activation Antigen CD86 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Asia Pacific: T Lymphocyte Activation Antigen CD86 Sales Forecast by Region (2021-2026) (K Pcs)
Table 94. Asia Pacific: T Lymphocyte Activation Antigen CD86 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 95. Latin America: T Lymphocyte Activation Antigen CD86 Sales Forecast by Country (2021-2026) (K Pcs)
Table 96. Latin America: T Lymphocyte Activation Antigen CD86 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Middle East and Africa: T Lymphocyte Activation Antigen CD86 Sales Forecast by Country (2021-2026) (K Pcs)
Table 98. Middle East and Africa: T Lymphocyte Activation Antigen CD86 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 100. Key Challenges
Table 101. Market Risks
Table 102. Main Points Interviewed from Key T Lymphocyte Activation Antigen CD86 Players
Table 103. T Lymphocyte Activation Antigen CD86 Customers List
Table 104. T Lymphocyte Activation Antigen CD86 Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. T Lymphocyte Activation Antigen CD86 Product Picture
Figure 2. Global T Lymphocyte Activation Antigen CD86 Sales Market Share by Type in 2020 & 2026
Figure 3. Abatacept Product Picture
Figure 4. Abatacept Biosimilar Product Picture
Figure 5. KAHR-102 Product Picture
Figure 6. Global T Lymphocyte Activation Antigen CD86 Sales Market Share by Application in 2020 & 2026
Figure 7. Musculoskeletal Disorders
Figure 8. Graft Versus Host Disease
Figure 9. Lupus Nephritis
Figure 10. Nephrotic Syndrome
Figure 11. Others
Figure 12. T Lymphocyte Activation Antigen CD86 Report Years Considered
Figure 13. Global T Lymphocyte Activation Antigen CD86 Market Size 2015-2026 (US$ Million)
Figure 14. Global T Lymphocyte Activation Antigen CD86 Sales 2015-2026 (K Pcs)
Figure 15. Global T Lymphocyte Activation Antigen CD86 Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global T Lymphocyte Activation Antigen CD86 Sales Market Share by Region (2015-2020)
Figure 17. Global T Lymphocyte Activation Antigen CD86 Sales Market Share by Region in 2019
Figure 18. Global T Lymphocyte Activation Antigen CD86 Revenue Market Share by Region (2015-2020)
Figure 19. Global T Lymphocyte Activation Antigen CD86 Revenue Market Share by Region in 2019
Figure 20. Global T Lymphocyte Activation Antigen CD86 Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by T Lymphocyte Activation Antigen CD86 Revenue in 2019
Figure 22. T Lymphocyte Activation Antigen CD86 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global T Lymphocyte Activation Antigen CD86 Sales Market Share by Type (2015-2020)
Figure 24. Global T Lymphocyte Activation Antigen CD86 Sales Market Share by Type in 2019
Figure 25. Global T Lymphocyte Activation Antigen CD86 Revenue Market Share by Type (2015-2020)
Figure 26. Global T Lymphocyte Activation Antigen CD86 Revenue Market Share by Type in 2019
Figure 27. Global T Lymphocyte Activation Antigen CD86 Market Share by Price Range (2015-2020)
Figure 28. Global T Lymphocyte Activation Antigen CD86 Sales Market Share by Application (2015-2020)
Figure 29. Global T Lymphocyte Activation Antigen CD86 Sales Market Share by Application in 2019
Figure 30. Global T Lymphocyte Activation Antigen CD86 Revenue Market Share by Application (2015-2020)
Figure 31. Global T Lymphocyte Activation Antigen CD86 Revenue Market Share by Application in 2019
Figure 32. North America T Lymphocyte Activation Antigen CD86 Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America T Lymphocyte Activation Antigen CD86 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America T Lymphocyte Activation Antigen CD86 Sales Market Share by Country in 2019
Figure 35. North America T Lymphocyte Activation Antigen CD86 Revenue Market Share by Country in 2019
Figure 36. U.S. T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America T Lymphocyte Activation Antigen CD86 Market Share by Type in 2019
Figure 41. North America T Lymphocyte Activation Antigen CD86 Market Share by Application in 2019
Figure 42. Europe T Lymphocyte Activation Antigen CD86 Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe T Lymphocyte Activation Antigen CD86 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe T Lymphocyte Activation Antigen CD86 Sales Market Share by Country in 2019
Figure 45. Europe T Lymphocyte Activation Antigen CD86 Revenue Market Share by Country in 2019
Figure 46. Germany T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe T Lymphocyte Activation Antigen CD86 Market Share by Type in 2019
Figure 57. Europe T Lymphocyte Activation Antigen CD86 Market Share by Application in 2019
Figure 58. Asia Pacific T Lymphocyte Activation Antigen CD86 Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific T Lymphocyte Activation Antigen CD86 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific T Lymphocyte Activation Antigen CD86 Sales Market Share by Region in 2019
Figure 61. Asia Pacific T Lymphocyte Activation Antigen CD86 Revenue Market Share by Region in 2019
Figure 62. China T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific T Lymphocyte Activation Antigen CD86 Market Share by Type in 2019
Figure 85. Asia Pacific T Lymphocyte Activation Antigen CD86 Market Share by Application in 2019
Figure 86. Latin America T Lymphocyte Activation Antigen CD86 Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America T Lymphocyte Activation Antigen CD86 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America T Lymphocyte Activation Antigen CD86 Sales Market Share by Country in 2019
Figure 89. Latin America T Lymphocyte Activation Antigen CD86 Revenue Market Share by Country in 2019
Figure 90. Mexico T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America T Lymphocyte Activation Antigen CD86 Market Share by Type in 2019
Figure 97. Latin America T Lymphocyte Activation Antigen CD86 Market Share by Application in 2019
Figure 98. Middle East and Africa T Lymphocyte Activation Antigen CD86 Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa T Lymphocyte Activation Antigen CD86 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa T Lymphocyte Activation Antigen CD86 Sales Market Share by Country in 2019
Figure 101. Middle East and Africa T Lymphocyte Activation Antigen CD86 Revenue Market Share by Country in 2019
Figure 102. Turkey T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E T Lymphocyte Activation Antigen CD86 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E T Lymphocyte Activation Antigen CD86 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa T Lymphocyte Activation Antigen CD86 Market Share by Type in 2019
Figure 109. Middle East and Africa T Lymphocyte Activation Antigen CD86 Market Share by Application in 2019
Figure 110. North America T Lymphocyte Activation Antigen CD86 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America T Lymphocyte Activation Antigen CD86 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe T Lymphocyte Activation Antigen CD86 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe T Lymphocyte Activation Antigen CD86 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific T Lymphocyte Activation Antigen CD86 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific T Lymphocyte Activation Antigen CD86 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America T Lymphocyte Activation Antigen CD86 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America T Lymphocyte Activation Antigen CD86 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa T Lymphocyte Activation Antigen CD86 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa T Lymphocyte Activation Antigen CD86 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---